United Imaging Intelligence Valuation, Funding & Investors

United Imaging Intelligence is valued at $1.4B as of June 2025.

Last United Imaging Intelligence valuation

$1.4B

Series A · Jun 2025

Last United Imaging Intelligence funding round

$139M

Series A · Jun 2025

Cumulative funding United Imaging Intelligence raised

$139M

across 1 funding round

Key investors in United Imaging Intelligence

  • Suzhou International Development Venture Capital
  • Qingsong Capital
  • Suzhou Innovation Investment Group
  • Wuhan Optics Valley Industrial Investment
  • Shanghai Alliance Investment
  • Zhangjiagang Industrial Capital

United Imaging Intelligence Overview

About United Imaging Intelligence

United Imaging Intelligence is a provider of AI-driven medical solutions covering diagnostics for all diseases. Based in Shanghai, China, it develops full-stack intelligent software for imaging analysis, radiotherapy planning, and healthcare workflows, integrating with United Imaging Healthcare's hardware.


Founded

2017

HQ

ChinaShanghai

Website

uii-ai.com

Status

Privately held

Customer focus

B2B

Revenue model

Subscription

Valuation

$1.4B (Jun 2025)

United Imaging Intelligence Valuation

United Imaging Intelligence is currently valued at $1.4B, based on its Series A in June 2025.

The $139M round was led by E Fund and Shangguo Investment Management, with participation from Suzhou Innovation Investment Group, Zhangjiagang Industrial Capital, Baolan Investment, Suzhou International Development Venture Capital, Qingsong Capital and 5 other investors.

United Imaging Intelligence valuation by funding round

United Imaging Intelligence valuation by funding round
DateStageValuation
Jun 2025Series A$1.4B

United Imaging Intelligence Funding History

United Imaging Intelligence has raised a total of $139M across 1 funding round.

United Imaging Intelligence funding rounds

United Imaging Intelligence funding rounds
DateStageInvestorsRaisedValuationDeal Summary
Jun 2025Series AE Fund (lead); Shangguo Investment Management (lead); Suzhou Innovation Investment Group; Zhangjiagang Industrial Capital; Baolan Investment; Suzhou International Development Venture Capital; Qingsong Capital; Sun Rock Capital; Wuhan Optics Valley Industrial Investment; All venture capital; United Imaging; Shanghai Alliance Investment$139M$1.4BUnited Imaging Intelligence (UII) is an artificial intelligence subsidiary of United Imaging Healthcare (UIH), focused on developing medical AI applications for imaging modalities such as PET/CT, mammography, MRI, and CT, targeting diseases in neurology, oncology, cardiovascular, pulmonary, and musculoskeletal areas. Founded with a $45 million investment from UIH, UII leverages UIH's medical imaging products, cloud platforms, and imaging centers for data acquisition and AI deployment. Professor Shen Dinggang, a renowned medical AI scholar, leads aspects of the subsidiary, emphasizing data-driven algorithms and clinical applications. UII has achieved significant regulatory milestones, including 31 CE-marked medical AI applications as of July 2025, with 18 additional approvals that year, positioning it as a leader in certified medical AI products globally. It also holds 15 FDA clearances and 15 Class III NMPA approvals, enabling broad clinical workflows from detection to research across modalities. At events like ECR 2026 and RSNA 2025, UII showcased its uAI Clinical Portal with over 60 AI applications, uAI NEXUS foundation models for image, language, speech, and video, and AI agents for diagnostics, surgical planning, and hospital operations.

Who has invested in United Imaging Intelligence?

12 investors have backed United Imaging Intelligence across its funding rounds, including Suzhou International Development Venture Capital, Qingsong Capital, Suzhou Innovation Investment Group, Wuhan Optics Valley Industrial Investment, Shanghai Alliance Investment and Zhangjiagang Industrial Capital.

Lead investors include E Fund and Shangguo Investment Management.


United Imaging Intelligence Investors

Investors in United Imaging Intelligence by funding rounds participated
InvestorHQRoundsRoleFirst check
Suzhou Innovation Investment GroupChinaSuzhou1ParticipantJun 2025
Zhangjiagang Industrial CapitalChinaZhangjiagang1ParticipantJun 2025
Baolan InvestmentChinaBeijing1ParticipantJun 2025
Suzhou International Development Venture CapitalChinaSuzhou1ParticipantJun 2025
Qingsong CapitalChinaBeijing1ParticipantJun 2025
Sun Rock CapitalChinaShanghai1ParticipantJun 2025
Wuhan Optics Valley Industrial InvestmentChinaWuhan1ParticipantJun 2025
All venture capitalUnited StatesSan Francisco, CA1ParticipantJun 2025
United ImagingChinaShanghai1ParticipantJun 2025
Shangguo Investment ManagementChinaShanghai1LeadJun 2025

This data is available for Pro users. Sign up to see all 12 United Imaging Intelligence investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

United Imaging Intelligence Competitors

United Imaging Intelligence competitors include listed companies like Lunit, United Imaging, GE HealthCare and RaySearch Labs, and private ones like Viz and IntelyCare.

Public and private companies comparable to United Imaging Intelligence
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
LunitSouth KoreaSouth KoreaPublicly listed$61M($9M)$450M6.4x
United ImagingChinaChinaPublicly listed$2.1B$367M$12B4.8x
GE HealthCareUnited StatesUnited StatesPublicly listed$21B$3.7B$29B1.8x
VizUnited StatesUnited StatesPrivate$100M-$1.3B12.8x
RaySearch LabsSwedenSwedenPublicly listed$137M$59M$583M4.2x
IntelyCareUnited StatesBoston, MAPrivate--$1.1B-

United Imaging Intelligence Public Comps

United Imaging Intelligence is still privately-owned, but its public comps include Ramsay Santé, EverCommerce, Diagnostyka, Indegene, Omnicell, Sinocare, U.S. Physical Therapy, SonoScape, Castle Biosciences and Lumexa Imaging.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Ramsay Santé$6.2B$720M0.9x-8.0x-
EverCommerce$589M$128M3.0x2.9x13.7x9.5x
Diagnostyka$637M$154M2.8x2.5x11.6x10.5x
Indegene$366M$68M3.7x3.3x19.9x18.2x
Omnicell$1.2B$92M1.2x1.1x15.0x8.1x
Sinocare$695M$43M1.9x1.8x31.0x15.3x
U.S. Physical Therapy$781M$110M2.5x2.3x17.5x18.9x
SonoScape$344M$35M3.1x2.8x30.1x24.4x

This data is available for Pro users. Sign up to see all United Imaging Intelligence competitors and their valuation data.

Start Free Trial

Common questions about United Imaging Intelligence

When was United Imaging Intelligence founded?United Imaging Intelligence was founded in 2017.
Where is United Imaging Intelligence headquartered?United Imaging Intelligence is headquartered in Shanghai, China.
Is United Imaging Intelligence publicly listed?No, United Imaging Intelligence is a private, VC-backed company.
What is United Imaging Intelligence's valuation?United Imaging Intelligence was last valued at $1.4B in its Series A in June 2025.
How much funding has United Imaging Intelligence raised?United Imaging Intelligence has raised $139M across 1 funding round.
What was United Imaging Intelligence's last funding round?United Imaging Intelligence's last funding round was a $139M Series A in June 2025, led by E Fund and Shangguo Investment Management.
Who are United Imaging Intelligence's investors?United Imaging Intelligence's investors include Suzhou Innovation Investment Group, Zhangjiagang Industrial Capital, Baolan Investment, Suzhou International Development Venture Capital, Qingsong Capital, Sun Rock Capital, Wuhan Optics Valley Industrial Investment, All venture capital, United Imaging, Shangguo Investment Management and 2 others.
Which companies are comparable to United Imaging Intelligence?Companies comparable to United Imaging Intelligence include Lunit, United Imaging, GE HealthCare, Viz, RaySearch Labs and IntelyCare.

See companies similar to United Imaging Intelligence

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial